Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR3 | O14843 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15114296 | 0.69 | ALDH1A1 (0.43) | FFAR3ALDH1A1TSHR | |
| SCHEMBL840303 | 0.67 | ADORA3 (0.33) | ALDH1A1TSHR | |
| SCHEMBL15114680 | 0.65 | FFAR3 (0.39) | FFAR3ALDH1A1TSHR | |
| SCHEMBL2558124 | 0.62 | FFAR3 (0.36) | FFAR3ALDH1A1TSHR | |
| SCHEMBL14892661 | 0.61 | FFAR3 (0.39) | FFAR3ALDH1A1TSHR | |
| SCHEMBL4540907 | 0.61 | ALDH1A1 (0.44) | FFAR3ALDH1A1TSHR | |
| SCHEMBL189665 | 0.61 | — | — | |
| SCHEMBL22440902 | 0.61 | ALDH1A1 (0.44) | FFAR3ALDH1A1TSHR | |
| SCHEMBL1197211 | 0.61 | ALDH1A1 (0.44) | FFAR3ALDH1A1TSHR | |
| SCHEMBL283370 | 0.61 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180221342-A1 | HEPATITIS C VIRUS INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2018-08-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180221342-A1 | HEPATITIS C VIRUS INHIBITORS | HAVCR2, MAVS, EIF2AK2 | FFAR3 4180/4885ALDH1A1 3966/4885TSHR 4427/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.